July 06, 2026 08:11 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough

Russia now has three drugs that can help treat COVID-19: Russian Academy of Sciences

| @indiablooms | Mar 30, 2020, at 12:32 pm

Moscow/Sputnik/UNI: Three antiviral drugs that can be used to treat COVID-19 were developed in Russia in conjunction with scholars from the Russian Academy of Sciences; the academy's vice president and head of the biomedical sciences unit Vladimir Chekhonin told Sputnik.

Chekhonin stated that the antiviral drug triazavirin was created several years ago at the Institute of Organic Synthesis at the Urals branch of the Russian Academy of Sciences. This drug is now being tested by Chinese scientists for its ability to treat COVID-19.

“As of today, a special inhalant is ready, which can be used exclusively to treat viral respiratory infections. I am sure that it will be more than appropriate to treat COVID-19. And of course, having this option is extremely important in the current circumstances,” he said.

The leading academician also stated that another drug, based on the Japanese-made antiviral treatment favipiravir, has been created by the Institute of Organic Synthesis in conjunction with the Zelinsky Institute of Organic Chemistry in Moscow. This drug has been adapted to meet Russian standards, he said.

“As far as I know, this drug is ready to be tested in specialized clinics in Russia,” Chekhonin stated.

Another viral drug, fortepren, has also passed clinical trials and should be assessed for its ability to treat COVID-19, the academician stated.

“As for fortepren, it has passed all its clinical trials, that is, it was even tested in humans. It is currently awaiting registration, after which it can be submitted for trials to see if it can treat COVID-19,” Chekhonin remarked.

According to the academician, testing the ability of these three drugs to treat the coronavirus disease is a top priority of both the Russian Academy of Sciences and the Russian Ministry of Education and Science. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.